Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Clinical perspectives of hybrid proton-fluorine magnetic resonance imaging and spectroscopy.

Wolters M, Mohades SG, Hackeng TM, Post MJ, Kooi ME, Backes WH.

Invest Radiol. 2013 May;48(5):341-50. doi: 10.1097/RLI.0b013e318277528c. Review.

PMID:
23211551
2.

Relaxometric studies of gadolinium-functionalized perfluorocarbon nanoparticles for MR imaging.

de Vries A, Moonen R, Yildirim M, Langereis S, Lamerichs R, Pikkemaat JA, Baroni S, Terreno E, Nicolay K, Strijkers GJ, Grüll H.

Contrast Media Mol Imaging. 2014 Jan-Feb;9(1):83-91. doi: 10.1002/cmmi.1541.

PMID:
24470297
3.

Quantitative (1)H MRI, (19)F MRI, and (19)F MRS of cell-internalized perfluorocarbon paramagnetic nanoparticles.

Kok MB, de Vries A, Abdurrachim D, Prompers JJ, Grüll H, Nicolay K, Strijkers GJ.

Contrast Media Mol Imaging. 2011 Jan-Feb;6(1):19-27. doi: 10.1002/cmmi.398. Epub 2010 Jul 21.

PMID:
20648660
4.

In vivo fluorine-19 MR imaging: relaxation enhancement with Gd-DTPA.

Lee H, Price RR, Holburn GE, Partain CL, Adams MD, Cacheris WP.

J Magn Reson Imaging. 1994 Jul-Aug;4(4):609-13.

PMID:
7949689
5.

Development and applications of in vivo clinical magnetic resonance spectroscopy.

Cox IJ.

Prog Biophys Mol Biol. 1996;65(1-2):45-81. Review.

PMID:
9029941
6.

Quantitative magnetic resonance fluorine imaging: today and tomorrow.

Chen J, Lanza GM, Wickline SA.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Jul-Aug;2(4):431-40. doi: 10.1002/wnan.87. Review.

7.

Simultaneous dual-nuclei imaging for motion corrected detection and quantification of 19F imaging agents.

Keupp J, Rahmer J, Grässlin I, Mazurkewitz PC, Schaeffter T, Lanza GM, Wickline SA, Caruthers SD.

Magn Reson Med. 2011 Oct;66(4):1116-22. doi: 10.1002/mrm.22877. Epub 2011 Mar 9.

8.

1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles.

Lanza GM, Winter PM, Neubauer AM, Caruthers SD, Hockett FD, Wickline SA.

Curr Top Dev Biol. 2005;70:57-76. Review.

PMID:
16338337
9.

Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.

Ala-Korpela M, Sipola P, Kaski K.

Ann Med. 2006;38(5):322-36. Review. Erratum in: Ann Med. 2006;38(7):528.

PMID:
16938802
10.

MRI of the prostate: clinical relevance and emerging applications.

Mazaheri Y, Shukla-Dave A, Muellner A, Hricak H.

J Magn Reson Imaging. 2011 Feb;33(2):258-74. doi: 10.1002/jmri.22420. Review.

PMID:
21274967
11.

Whole-body high-field-strength (3.0-T) MR Imaging in Clinical Practice. Part I. Technical considerations and clinical applications.

Kuhl CK, Träber F, Schild HH.

Radiology. 2008 Mar;246(3):675-96. doi: 10.1148/radiol.2463060881. Review.

PMID:
18309012
12.

A temperature-sensitive liposomal 1H CEST and 19F contrast agent for MR image-guided drug delivery.

Langereis S, Keupp J, van Velthoven JL, de Roos IH, Burdinski D, Pikkemaat JA, Grüll H.

J Am Chem Soc. 2009 Feb 4;131(4):1380-1. doi: 10.1021/ja8087532.

PMID:
19173663
13.

Fluorine nuclear magnetic resonance: calibration and system optimization.

Nelson TR, Newman FD, Schiffer LM, Reith JD, Cameron SL.

Magn Reson Imaging. 1985;3(3):267-73.

PMID:
4079674
14.

Advanced magnetic resonance imaging techniques in the evaluation of musculoskeletal tumors.

Costa FM, Canella C, Gasparetto E.

Radiol Clin North Am. 2011 Nov;49(6):1325-58, vii-viii. doi: 10.1016/j.rcl.2011.07.014. Review.

PMID:
22024301
15.

Molecular imaging techniques in body imaging.

Margolis DJ, Hoffman JM, Herfkens RJ, Jeffrey RB, Quon A, Gambhir SS.

Radiology. 2007 Nov;245(2):333-56. Review.

PMID:
17940297
16.

Assessment of lung ventilation by MR imaging: current status and future perspectives.

Kauczor HU, Hanke A, Van Beek EJ.

Eur Radiol. 2002 Aug;12(8):1962-70. Epub 2002 May 24. Review.

PMID:
12136314
17.

19F-MRI of perfluorononane as a novel contrast modality for gastrointestinal imaging.

Schwarz R, Schuurmans M, Seelig J, Künnecke B.

Magn Reson Med. 1999 Jan;41(1):80-6.

PMID:
10025614
18.

Cardiovascular molecular MR imaging.

Lamb HJ, van der Meer RW, de Roos A, Bax JJ.

Eur J Nucl Med Mol Imaging. 2007 Jun;34 Suppl 1:S99-104. Review.

19.

In vivo 19F NMR imaging of liver, tumor, and abscess in rats. Preliminary results.

Longmaid HE 3rd, Adams DF, Neirinckx RD, Harrison CG, Brunner P, Seltzer SE, Davis MA, Neuringer L, Geyer RP.

Invest Radiol. 1985 Mar-Apr;20(2):141-5.

PMID:
3988465
20.

MR imaging of the breast. Imaging and tissue characterization without intravenous contrast.

Santyr GE.

Magn Reson Imaging Clin N Am. 1994 Nov;2(4):673-90. Review.

PMID:
7489316
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk